Cover Image

Clinical behavioral outcomes related to osteoporotic patients during ozone treatment.


Abstract


Bio-oxidative therapies accelerate oxygen metabolism, stimulate the antioxidant defense system, having analgesic, anti-inflammatory and immunomodulatory properties, among others.

A quasi-experimental study was carried out with the objective of knowing the clinical behavior of osteoporosis during ozone treatment at the Provincial Center for retinitis pigmentosa, Camagüey (Cuba) from January - June 2006.

The universe: 53 patients, 50 cases that met the inclusion criteria: patients with osteoporosis, those who agreed to participate in the study with prior informed consent and who decided to join the study by suspending or eliminating previously used therapies.
Ozone was rectally applied, 20 sessions in 2 cycles per year.

It was registered the following variables: age groups and sex, evaluation of signs and symptoms, distribution according to occupation, clinical evolution according to cycles, variation of drug treatment and social and economic impact.

The predominant ages: 31-40 and +41 years with 16 (32%) and 21 (42%) respectively, the main symptom pain 50 (100%), occupation: workers: 42 (84%). After 20 sessions of ozone, the results were: improved 38 (76%), 50 (100%) decreased the dose of medications.

Patients were incorporated into society in less time, improving their bio-psycho-social state with a cost five times lower than the standard treatment.

Keywords


ozone; bioxidants; patients; osteoporosis

Full Text:

PDF

References


  1. Copello M, Eguía F, Menéndez S, Menéndez N. Ozone therapy in patients with Retinitis Pigmentosa. Ozone-Sci Eng. 2003;25(3):223-232.

  2. Peláez O. Retinitis Pigmentaria. Experencia Cubana. [Retinitis Pigmentaria. Cuban Experience] La Habana: Ed. Cientifico-Técnica; 1995.

  3. Viebahn, R. The use of ozone in Medicine. 3 English ed. Iffezheim (DE): ODREI Publishers; 1999. p. 95-119.

  4. Richelmi P, Franzini M, Valdenassi L. Ossigeno-Ozono Terapia [Oxygen ozone therapy]. 4 ed. Torini (IT): CAST; 1995.

  5. Rilling S. The basic clinical applications of ozone therapy. Ozone-Sci Eng. 1985;7(4):259-274. doi: 10.1080/01919518508552307.

  6. Bocci V. Ozone therapy today. In: International Ozone Association, editors. Proceedings of the 12th Ozone World Congress; 1995 May 15-18; Lille, France. International Ozone Association; 1995. Ozone in Medicine: 13-28.

  7. Menéndez S, Iglesias O, Bidot C, Puga A, Carballo A. Application of ozone therapy in children with humoral immunity deficiency. In: International Ozone Association, editors. Proceedings of the 12th Ozone World Congress; 1995 May 15-18; Lille, France. International Ozone Association; 1995. Ozone in Medicine: 271-274.

  8. Martin-Gonzalez IC, Plasencia-Concepcion D, Gonzalez-Perez TL. Manual de dietoterapia [Diet therapy manual]. La Habana: Ed Ciencias Médicas; 2001:44-48,143-144.

  9. Williams R. Textbook on Endocrinology. 5 ed. Barcelona: Elsevier; 1996:1100-1106.

  10. Kleerekoper M, Alvioli LV. Osteoporosis, pathogenesis and therapy. In: Alvioli LV, Krane SM. Metabolic bone disease and clinically related disorders. New York: Academic Press; 1998: 307.

  11. Jowsey J, Johnson KA. Juvenile osteoporosis: bone findings in seven patients. J Pediatr. 1972 Sep;81(3):511-7. doi: 10.1016/s0022-3476(72)80178-1.

  12. Rosenberg E, Lang R, Boisseau V, Rojanasathit S, Avioli LV. Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta. J Clin Endocrinol Metab. 1977;44(2):346-355. doi: 10.1210/jcem-44-2-346.

  13. Aitken, JM. Bone metabolism in post-menopausal women. In: Beard RJ. The Menopause, a guide to current research and practice. Baltimore: University Press; 1976.

  14. Aloia JF, Vaswani A, Atkins H, Zanzi I, Ellis K, Cohn SH. Radiographic morphometry and osteopenia in spinal osteoporosis. J Nucl Med. 1977;18(5):425-431.

  15. Coop DH, Talmage RV. Endocrinology of calcium metabolism: proceedings of the sixth Parathyroid Conference, Vancouver, Canada. June 12-17, 1977. Amsterdam: Excerpta Medica; 1978.

  16. Horsman A. Bone mass. In: Nordin BEC. Calcium, phosphate, and magnesium metabolism: clinical physiology and diagnostic procedures. London: Churchill-Livingstone; 1976.

  17. Basabe E, Menendez S, Ponce de Leon S. Ozone Therapy like a favoring. Element in the realitation children with hearings loss. In: International Ozone Association, editors. Proceedings of the 12th Ozone World Congress; 1995 May 15-18; Lille, France.

  18. Sunnen GV. Ozone in medicine: overview and future directions. J. Adv. Med. 1988;1(3):159–174.


Refbacks

  • There are currently no refbacks.